The HIVconsv Vaccines Induce Polyfunctional and Highly Proliferative T Cells that Control In Vitro HIV Replication: HIV-CORE002 Phase-I Clinical Trial
Главные авторы: | Ondondo, B, Ahmed, T, Nicola, B, Hayton, E, Vasilyeva, E, Frahm, N, Colloca, S, Nicosia, A, McMichael, A, Dorrell, L, Hanke, T |
---|---|
Формат: | Conference item |
Опубликовано: |
2013
|
Схожие документы
-
Phase I Clinical Trial HIV-CORE002 of a Universal T-cell Vaccine: One Year Follow On and Epitope Mapping
по: Borthwick, N, и др.
Опубликовано: (2013) -
Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice.
по: Ondondo, B, и др.
Опубликовано: (2013) -
Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice
по: Ondondo, B, и др.
Опубликовано: (2013) -
Targeting HIV-1 Where It Hurts
по: Ahmed, T, и др.
Опубликовано: (2013) -
Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects
по: Hancock, G, и др.
Опубликовано: (2017)